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Given the promise of carbon nanotubes (CNTs) for photothermal therapy, drug delivery, tissue 




CNT distribution and fate in the body. In this study non-ionizing whole-body high field 
magnetic resonance imaging (MRI) is used to follow the distribution of water-dispersible non-
toxic functionalized CNTs administrated intravenously to mice. Oxidized CNTs are endowed 
with positive MRI contrast properties by covalent functionalization with the chelating ligand 
diethylenetriaminepentaacetic dianhydride (DTPA), followed by chelation to Gd3+. The 
structural and magnetic properties, MR relaxivities, cellular uptake and application for MRI 
cell imaging of Gd-CNTs in comparison to the precursor oxidized CNTs are evaluated. Despite 
the intrinsic T2 contrast of oxidized CNTs internalized in macrophages, the anchoring of 
paramagnetic gadolinium onto the nanotube sidewall allows for efficient T1 contrast and MR 
signal enhancement, which is preserved after CNT internalization by cells. Hence due to their 
high dispersibility Gd-CNTs have the potential to produce positive contrast in vivo following 
injection into the bloodstream. The uptake of Gd-CNTs in the liver and spleen is assessed using 
MRI, while rapid renal clearance of extracellular Gd-CNTs is observed, confirming the 







Carbon nanotubes (CNTs) have great promise for numerous technological as well as biomedical 
applications, which arise from their unique architecture and their outstanding mechanical and 
electronic properties.[1] However, their toxicity and fate in the organism is still a subject of 
debate. The lack of consensus on a range of toxicology and biodistribution issues regarding 
CNTs is due, on one part, to the wide heterogeneity of CNTs used in terms of length, diameter, 
number of walls, purity (e.g. the presence of catalysts), morphology, functionalization, and 
aggregation state.[2] An additional confounding factor is the limited range of methods available 
to study CNTs, and more generally carbon-based materials, in biological environments.[3] As 
pristine CNTs are water insoluble, a variety of chemical strategies have been explored to 
functionalize the nanotube surface and render them dispersible in aqueous media.[4] The type 
of surface modification e.g. physical coating as opposed to covalent chemical functionalization, 
has been shown to play a critical role in the interactions of CNTs with cells, in their behavior 
in the blood compartment and in their subsequent fate in vivo.[5] In particular, oxidation and 
shortening of multi-walled carbon nanotubes (MWCNTs) by acid treatment followed by 
chemical functionalization of the hydrophobic carbon structure with hydrophilic amino groups 
has led to a new generation of functionalized MWCNTs with high dispersibility, low toxicity, 
high cellular uptake and favorable pharmacokinetics for medical use.[6] Although functionalized 
MWCNTs have very promising applications, as they can serve as multifunctional platforms for 
tumor targeting and drug delivery,[7] therapeutic hyperthermia,[8] transfection of siRNA,[9] and 
tissue engineering.[10], imaging of MWCNTs in vivo remains a major challenge. 
Under controlled conditions imaging of CNTs in biological environments can be achieved using 
the intrinsic properties of the nanotubes, such as light absorption and scattering,[11] acoustic or 
photoacoustic properties,[12] Raman signature[13] or electron microscopy.[14] However, with 




radionuclides[16]) are usually required for efficient non-invasive tracking of CNTs in living 
animals.[17] 
Among non-invasive imaging methods, magnetic resonance imaging (MRI) appears 
particularly advantageous because of its excellent spatial resolution and soft-tissue contrast 
providing simultaneously anatomic, functional and molecular information. The main advantage 
of MRI over other modalities, such as fluorescence or nuclear imaging, is its ability to penetrate 
deep into tissue without employing ionizing radiation. In addition to the enormous, and ongoing, 
growth in its application in routine clinical practice, MRI has also proven to be a method of 
choice for molecular imaging, providing cell tracking and direct information on molecular 
events through the use of smart contrast agents. To date there have been few reports on the use 
of MRI for visualization of CNTs due to the poor MR contrast generated by CNTs. Recently 
the magnetic properties of metal impurities present in raw commercially-available single-
walled CNTs (mainly iron and nickel catalysts) were exploited to investigate CNT distribution 
with hyperpolarized 3He and conventional 1H MRI.[18] However, the intrinsic T2 and T2* 
contrast that are exploited in this approach are highly dependent on the quality of purification, 
on the type of CNTs, and indeed on the aggregation propensity in physiological media;[19] all 
factors which are not easily controllable. Alternatively, CNTs may be coupled to exogenous 
contrast agents. These agents may allow both, the T2 contrast and signal reduction, as for 
example is the case of CNT conjugates with iron oxide superparamagnetic nanoparticles[16b,20] 
or provide T1-based contrast and signal enhancement when the tubes are conjugated to 
paramagnetic gadolinium[21]. The CNT-contrast agent complexes might be either made by 
loading the tube cavity or by functionalization of their carbon backbone. For the goal of 
monitoring the behavior of CNTs in vivo, it is important that any exogenous agent does not 
influence either the CNT biodistribution, or their ability to transport and deliver a therapeutic 
agent to an identified target. In this regards both external coupling to or internal loading of 
CNTs with iron oxide nanoparticles may partially modify their fate in vivo, as the organism 
must degrade inorganic nanoparticles in addition to carbon materials, which are both slow 
processes.[22] Alternative strategies such as nanoscale confinement of large quantities of Gd 
within ultra-short SWCNTs through sidewall defects or at the opened ends (so called 
gadonanotubes),[23] synthesis of SWCNT-Gd oxide complexes by use of Gd2O3 catalytic 
nanoparticles[24] or non-covalent adsorption of Gd3+ chelates onto MWCNT surface[25] have 
been shown to produce agents with very high r1 relaxivity (relaxation enhancement per 




of saturating the loading capacity of CNTs or strongly reducing the possibility of further 
functionalization. In addition, most of these Gd-CNT complexes have unknown behavior in 
vivo, especially after intravenous injection due their poor dispersibility. Only one recent study 
described intravenous administration of a low dose of SWCNTs, synthesized using gadolinium 
nanoparticles as catalysts, however an in vivo MRI follow-up was not reported and the fate of 
gadolinium nanoparticles is not known.[26] In this context, our goal was to produce water-
dispersible non-toxic functionalized short MWCNTs suitable for targeting and delivery of 
drugs[7a] with fully characterized MRI contrast properties. The critical point was to endow 
carbon nanotubes with positive contrast properties without interfering with the nanotube 
structure and fate. We proposed a covalent grafting of molecular paramagnetic species on the 
nanotubes. 
For this purpose, oxidized MWCNTs were covalently functionalized with the chelating 
molecule diethylenetriaminepentaacetic dianhydride (DTPA), followed by chelation to Gd3+. 
As our approach is based on covalent bonding between CNTs and DTPA, which has a high 
association constant for Gd3+, the chelation of Gd3+ by DTPA/CNTs is strong, resulting in stable 
Gd-CNT conjugates and thus reducing the risk of Gd3+ release.  
 The magnetic properties and magnetic resonance relaxivities of the Gd-CNTs in comparison 
to Ox-CNT showed the paramagnetic contribution of Gd-chelates which led to positive MR 
contrast. Remarkably these nanotubes were internalized by cells without toxicity and the 
positive contrast effect was preserved following cell internalization.  Finally, the potential for 
in vivo monitoring of nanotube fate following intravenous administration of Gd-CNTs in mice 
was assessed demonstrating that MRI can be used as suitable alternative imaging technique to 
track CNTs in vivo. 
 
2. Results and discussion 
2.1. CNT functionalization 
 
MWCNTs with a diameter of 20-30 nm functionalized with a DTPA derivative were prepared 
using a four step procedure (Figure 1). Pristine purified MWCNTs were first oxidized in acidic 
conditions to shorten the tubes to an average length of ~ 400 nm and to introduce COOH groups 
(Supporting Figure S1).[27] The carboxylic acids were activated using oxalyl chloride. The 




amine function (Supporting Figure S2).[25,28] The tert-butyl ester moieties were subsequently 
hydrolyzed using trifluoroacetic acid (TFA). Finally, chelation of Gd3+ was achieved by 
dispersing the DTPA/CNTs 4 in an aqueous solution of gadolinium(III) perchlorate, followed 
by dialysis against water to remove free gadolinium. The usual approach to conjugation of 
molecules with DTPA involves the conversion of one of the four carboxylic acids to an amide 
functionality by the use of DTPA dianhydride. In addition to the disadvantage of being non-
selective, due to the concomitant formation of diamide derivatives, this method results in 
conjugates with lower chelating capacity for gadolinium.[29] In our case the DTPA derivative 2 











































































Figure 1:  Preparation of Gd-CNTs 5. 
 
The Gd-CNTs were characterized by thermogravimetric analysis (TGA), inductively coupled 
plasma atomic emission spectrometry (ICP-AES), high resolution transmission electron 
microscopy (HR-TEM) and scanning transmission electron microscopy (STEM) coupled to 
energy-dispersive X-ray spectroscopy (EDX). TGA in N2 of pristine MWCNTs, oxidized 
MWCNTs (ox-CNTs) 1 and DTPA/CNTs 4 showed an increasing weight loss, confirming the 
efficiency of the functionalization (Figure 2A). The weight loss difference at 500 °C between 




DTPA loading was estimated 540 µmol per gram of CNTs. The level of functionalization was 
also determined spectrophotometrically using xylenol orange.[30] For this purpose, after 
chelation of DTPA/CNTs 4 with gadolinium(III) perchlorate and before filtration and dialysis, 
the free Gd (i.e. not chelated to DTPA/CNTs) was titrated. The dye xylenol orange is used as 
complexometric indicator of gadolinium as it shows a colour change in the presence of free Gd. 
This colorimetric test allowed us to determine that the amount of bound gadolinium was 485 
µmol per gram of CNTs 5, which is consistent with the value obtained from TGA. The xylenol 
orange test was also performed to ensure that no free Gd3+ was present in the Gd-CNT samples. 
Control reactions were performed using the precursor CNTs (i.e. ox-CNTs 1). In this case, we 
did not observe a significant complexation of Gd3+ ions by the carboxylic acid functions or the 
nanotube sidewall. Finally, ICP/AES of Gd-CNTs 5 gave a more precise value of the 
functionalization degree; 460 ± 4 µmol of gadolinium per gram of nanotubes. Overall, 
characterization of the CNT conjugates by ICP/MS, TGA, and xylenol orange test is consistent 
and demonstrate full chelation of Gd3+ by DTPA. TEM analysis of Gd-CNTs 5 show that 
conditions used for functionalization did not alter the morphology and dispersion of the 
nanotubes (Supporting Figure S1). The ultrastructure of Gd-CNTs 5, detailed by HR-TEM, 
revealed structural defects and dislocations within the external graphene layers on which it is 
likely that the functional groups and Gd-DTPA are anchored (Figure 2B). Gd-CNTs were also 
characterized using high angle annular dark field (HAADF)-STEM where the intensity in the 
image is proportional to the atomic number of the elements present in the sample. HAADF-
STEM has been shown as a powerful technique to allow the direct visualization of heavy-
element bearing organic molecules down to the atomic scale.[31] In the HAADF-STEM images 
of Gd-CNTs 5, bright dots correspond to the Gd atoms (Figure 2C), while they did not appear 
in the HAADF-STEM images of DTPA/CNTs 4. The presence of gadolinium in Gd-CNTs 5 





Figure 2 : A) Thermogravimetric analyses of pristine MWCNTs, ox-CNTs 1, and DTPA/CNTs 
4 performed in N2 atmosphere. B) Representative HR-TEM micrographs of Gd-CNTs 5 
showing structural defects and dislocations within the external graphene layers in which Gd-
DTPA may anchor. Inset shows the interlayer distance between graphene sheets  C) 
HAADF/STEM images of DTPA/CNTs 4 (upper images) and Gd-CNTs 5 (lower images). 
Groupings of Gd atoms might produce bright spots on HAADF due to the Z-contrast 
mechanism. D) Comparison of EDX spectrum of DTPA/CNTs 4 and Gd-CNTs 5 confirming 





Magnetic characterization confirmed the paramagnetic properties of Gd-CNTs 5 in comp arison 
with the ox-CNT precursor 1. The field-dependent magnetization curve at 5 K (Figure 3A) was 
fit using a Brillouin function characteristic of paramagnetic materials, with a J angular 
momentum of 3.2. This gives an effective magnetic moment of 6.9 µB, close to the theoretical 
magnetic moment of Gd3+ (µeff=7.94 µB, J=7/2). However, field-cooled (FC) and zero-field-
cooled (ZFC) magnetization measurements (using magnetic fields of 100 and 1000 Oe for the 




paramagnetic contribution arising from gadolinium. The FC and ZFC magnetization curves 
were not strictly superimposable as expected for purely paramagnetic behavior (inset in Figure 
3B). Interestingly, the low temperature ferromagnetic component (with a blocking temperature 
of about 65 K) was also displayed by the gadolinium-free control nanotubes (ox-CNTs) (Figure 
3C). This suggests that the ferromagnetic contribution arises from residual catalyst impurities 
(620 ppm of iron and 1283 ppm of nickel), which are probably entrapped into the inner empty 
cavity of CNTs and were not completely eliminated by the acid treatment, for both ox-CNTs 
and Gd-CNTs. The chelation of gadolinium into DTPA/CNTs gives rise to the stronger 
paramagnetic contribution, demonstrated by the linear dependence of magnetization with 
inverse temperature. 
 
Figure 3 : A) Magnetization curve of Gd-CNTs 5 at 5K. The solid line indicates the fit using a 
Brillouin function. B) FC and ZFC temperature dependent magnetization of Gd-CNTs 5 
registered at two different magnetic fields: 1000 Oe (black diamonds) and 100 Oe (gray 
diamonds). The shoulder at low temperature (<70 K) indicates the presence of a ferromagnetic 
component. The inset shows the magnetization as a function of inverse temperature. A purely 
paramagnetic sample would display a linear increase with inverse temperature. C) FC and ZFC 
magnetization curves (magnetic field 100 Oe) for the ox-CNTs 1. D) 1H magnetization 
longitudinal relaxation rate (1/T1) recorded at 25 oC as a function of Gd concentration for Gd-




T (200 MHz). The linear slope yields the relaxivity r1 of Gd-CNTs. E) NMRD profiles (r1 as a 
function of 1H Larmor frequency) recorded at 25 oC for Gd-CNTs 5 in comparison to Gd-DTPA 
8. 
  
MRI contrast agents (CAs) act as enhancers of longitudinal and transverse local 1H relaxation 
rates R1=1/T1 and R2=1/T2. The efficacy of a gadolinium-based CA is measured by its 
relaxivities r1 and r2 defined as ri=(Ri-Ri0)/[Gd], where i=1,2 and Ri0 is the endogenous 
relaxation rate (Figure 3D). Gd-DTPA (Magnevist, Bayer Schering Pharma) is one of the most 
common clinically approved CAs used in the majority of clinical procedure.[32] It has r1 value 
of 4.1 s-1mM-1 and r2 of 4.6 s-1mM-1  at an imaging field of 1.5 T (or 60 MHz 1H Larmor 
frequency). A relaxivity ratio r2/r1 of close to 1 ensures that the CA acts as a good local signal 
enhancer (a positive CA), particularly in T1-weighted sequences. Here, the MR properties of 
Gd-CNTs are compared to those of a Gd-DTPA chelate we synthesized (Supporting Figure 
S5). The longitudinal relaxivities, r1, were measured at 25 °C over a large range of 1H Larmor 
frequencies (from 0.01 to 200 MHz). Interestingly, the resulting nuclear magnetic relaxation 
dispersion (NMRD) profile of the Gd-CNT suspension is distinctly different from that of non-
conjugated Gd-DTPA, with r1 values enhanced by a factor of two at low frequency (Figure 3E). 
The decrease of r1 at clinical fields above 10 MHz is less marked for the Gd-CNTs in 
comparison to Gd-DTPA. However, the result is a three-fold increase in r1 at 200 MHz (4.7 T) 
due to conjugation to CNTs. This effect could be due to an enhancement of the inner-sphere 
relaxivity mechanism by slowing down the tumbling of Gd-chelates which exhibit fast 
exchange of the coordinated water molecules. This characteristic effect has been achieved 
before by binding Gd ions to objects of increasing size from macromolecules to proteins or 
nanoparticles.[33] In our case, the nearly one-dimensional structure of functionalized CNTs 
together with their high dispersibility, highly hydrated surface and high permeability to water 
may favor water exchange, while increasing the correlation time for tumbling of the whole 




covalent confinement of Gd-complexes or gadolinium oxide into nanosystems permeable to 
water, such as zeolites, apoferritin, silicon microparticles and single-walled carbon nanotubes 
was not observed.[23a,34] This is consistent with an external covalent coupling of water-
accessible Gd-chelates at the surface of the oxidized nanotubes. It should also be noted that we 
did not observe variations of relaxivity with CNT concentration, as previously reported.[25] All 
relaxation rates showed linear variation with CNT and Gd concentration with identical r1 
relaxivities whether CNTs have been dispersed in water or further immobilized in agarose gel 
(Figure 3D). All relaxation rates showed linear variation with CNT and Gd concentration, with 
identical r1 values obtained irrespective of whether the Gd-CNTs were dispersed in water or 
immobilized in agarose gel (Figure 3D). The former observation confirms both the remarkably 
high dispersibility of the functionalized CNTs and their colloidal stability in water suspension 
over the concentration range studied. The latter suggests that further increases in the overall 
tumbling correlation time (in agarose) have no effect, and so this is no longer the r1-limiting 
process. Once bound to the CNT it seems that the timescale for local dynamics about the chelate 
determines the relaxivity. 
Transverse relaxivities r2 were measured in the frequency range between 20 MHz (0.47 T) and 
200 MHz (4.7 T). The values of r2 of Gd-CNTs and Gd-DTPA decreased from 13.0 s-1 mM-1 
and 5.40 at 20 MHz to 5.22 s-1mM-1 and 4.07 s-1mM-1 at 200 MHz, respectively. This change 
corresponds to an evolution of the r2/r1 ratio from 1.8 to 0.7 for Gd-CNTs and from 1.42 to 1.40 
for Gd-DTPA when the imaging field is increased from 0.47 to 4.7 T. Hence, in terms of r2/r1 
ratio, the efficacy as a positive CA is enhanced for Gd-CNTs on increasing the field, in 
comparison to Gd-DTPA. Therefore, for the in vitro and in vivo evaluation of Gd-CNTs, an 
imaging field of 4.7 T was used. 
 





As intrinsic MR contrast highly depends on tissue structure and water dynamics, the ability of 
a CA to modify the 1H signal is strongly affected by the local environment and by CA 
organization in this environment. During their odyssey through the organism, CNTs are likely 
internalized by cells, and most probably by cells of the reticulo-endothelial system (resident 
macrophages or circulating phagocytic cells). However, the magnetic properties of MRI 
contrast agents are deeply affected by cellular internalization and intracellular 
compartmentalization. For instance it is well-known that there is a drastic reduction of the 
longitudinal relaxivity of iron oxide nanoparticles following cellular uptake.[35] Similar effects 
were observed for gadolinium oxide nanoparticles depending on the internalized dose[36] and 
for a macromolecular Gd(III)-based probe[37] depending on its intracellular localization.[38] This 
so-called intracellular “quenching” effect tends to enhance r2/r1 ratio, in such manner that the 
generation of positive contrast by labeled cells becomes challenging. Regarding CNTs, it is not 
clear how r1 could be modified by cell confinement and how intrinsic properties of precursor 
ox-CNTs could affect transverse and longitudinal relaxation in that environment. It was 
reported that, despite a very high r1 value in suspension, gadolinium-loaded SWCNTs failed to 
induce positive contrast when internalized by murine macrophages and were subsequently 
detected with a negative signal on T2 or T2*-weighted sequence.[21c] Likewise, CNTs that were 
free of any gadolinium label[18b] were found to induce 1H signal suppression in mouse liver. 
These confusing results call for a thorough examination of MR properties depending on cellular 
uptake and on the intrinsic magnetic properties of CNTs. In this work, RAW 264.7 mouse 
macrophages were used as a cell model to study Gd-CNT uptake in vitro. The cells were 
incubated for 24 hours with Gd-CNTs in the concentration range of 0-100 µg/mL. Cell 
morphology and adherence on culture flasks was not affected by CNT labeling as shown by 
optical microscopy (Figure 4A). Cellular metabolic activity, assessed by the Alamar blue test, 
revealed a slight decrease in comparison to non-labelled cells at the highest concentration tested 




indeed elongated hollow structures were easily identifiable within the intracellular organelles 
(Figure 4B). Most nanotubes were assembled as large bundles within vesicular membranes, 
only a small fraction could be observed isolated within the cytoplasm. This suggests an active 
process of cellular internalization, involving membrane trafficking and dynamic 
compartimentalization within lysosomal storage organelles. The dose dependent CNT uptake 
by macrophages was assessed by imaging flow cytometry (ImageStream®).[11b] This technique 
combines the statistical power of high throughput flow cytometry with imaging of each 
analyzed cell.[11b,39] As illustrated in Figure 5A, Gd-CNT-labeled cells exhibit dark spots on 
bright field images that were not observed in non-labeled cells. These dark spots colocalized 
with high intensity spots on the dark field image, corresponding to areas of CNT accumulation 
that strongly absorb and scatter the light. The biparametric dot plot representing the mean 
intensity on dark field versus the mean pixel intensity on bright field (Figure 5B) clearly shows 
that both parameters increase (in absolute value) with increasing concentration of CNTs in the 
incubation medium. This indicates a dose dependent CNT uptake for the entire cell population, 
which tends to saturate at the highest concentration. Similar results were obtained for both Gd-





Figure 4 :  A) Optical micrographs of RAW 264.7 mouse macrophages after 20 h incubation 
with Gd-CNTs 5 at concentrations of 10, 20, 50 and 100 µg/mL. B) Electron micrographs of 
RAW cells incubated with 20 µg/mL of Gd-CNTs 5 for 20 h. Isolated Gd-CNTs and bundles 
of Gd-CNTs can be observed inside membrane-bound endosomes.  
 
 
Figure 5 : Imaging flow cytometry analysis of Gd-CNT uptake by RAW 264.7 macrophages. 
A) Representative bright field and corresponding dark field images of cells (among 10 000) 
acquired with ImageStream® for different Gd-CNT incubation conditions. Black spots on 




uptake. B) Relative quantification of Gd-CNT uptake on biparametric dot plot of dark field 
intensity versus mean pixel intensity on bright field image. 
 
Subsequently the MR contrast properties of cells labeled with increasing concentration of Gd-
CNTs or ox-CNTs and dispersed in agarose gels mimicking the cell density of tissue (7×106 
cells in 70 µL of gel) were examined. MR images were acquired using a spin echo sequence, 
while varying the echo time TE or repetition time TR in order to determine T1 and T2 values and 
the optimal conditions for T1- or T2-weighting. Representative T1-weighted images in Figure 
6A show a dose-dependent signal increase in the macrophages labeled with Gd-CNTs in 
comparison to the non-labeled cells or to the cells labeled with ox-CNTs. The signal increase 
was nearly two-fold for the highest Gd-CNT concentration with respect to non-labeled cells. 
Conversely, in T2-weighted images, the macrophages labeled with Gd-CNTs display decreased 
MR signal intensity with increasing CNT concentration (Figure 6A). Hence, the Gd-CNTs act 
as a bimodal contrast agent for cell imaging, generating positive contrast under T1-weighted 
and negative contrast under T2-weighted imaging conditions. By comparison, no signal change 
was observed for macrophages labeled with ox-CNTs. The quantitative determination of 
relaxation rates (1/Ti expressed in s-1, i=1,2) reveals a linear increase of 1/T1 with Gd-CNT 
concentration in macrophages, whereas no variation was observed after labeling with control 
ox-CNTs (Figure 6B). This shows that Gd-DTPA chelates covalently coupled to CNTs can 
still be effective as T1-contrast agents when internalized in cells. Regarding the transverse 
relaxation, the analysis is more complex. In comparison to cell-free agarose, the high density 
of cells induces a 3-fold increase in transverse relaxation time 1/T2 (Figure 6B). This 
observation is consistent with relaxation dynamics in tissue, which is accelerated in comparison 
to water.[40] More surprisingly, 1/T2 also increased with the concentration of CNTs in cells, 
regardless of whether they were labeled with Gd-CNTs or ox-CNTs. The T2 effect appears as 




covalent grafting of Gd-DTPA induces an efficient intracellular T1 reduction that depends on 
CNT cellular uptake. Despite the associated T2 reduction in labeled cells arising from the 
nanotubes, positive cell contrast due to the paramagnetic label can be observed when 
appropriate T1-weighting is applied.  
 
 
Figure 6 : A) T1-weighted and T2-weighted fast spin echo MR images of compacted cells 
mimicking tissue (70 µL) labeled with different concentrations (10, 20, 50 and 100 µg/mL) of 
Gd-CNTs 5 or ox-CNTs 1. For comparison, images of agarose gel alone (agar), water alone or 
non-labeled cells (cells) are also displayed. TE/TR are respectively 445/12 ms for T1-weighted 
sequence and 4500/95 ms for T2-weighted sequence. B) Longitudinal, 1/T1, and transverse, 






2.4. In vivo imaging 
 
 
The next step was to evaluate the use of Gd-CNTs in vivo to monitor the organ biodistribution 
of functionalized nanotubes. Gd-CNTs were injected intravenously to mice at two different 
doses (50 µg and 250 µg corresponding to 2.5 and 12.5 mg/kg, respectively) and monitored 
over 5 hours following injection. A T1-weighted sequence (fast spin echo) was applied since it 
offered the best contrast-to-noise ratio after Gd-CNT administration. Following the injection of 
the low dose of Gd-CNTs, significant signal changes in liver, spleen, kidneys and bladder were 
not observed. However a five-fold increase in Gd-CNT dose (250 µg corresponding to a 
gadolinium dose of 5.75 µmol/kg body weight) yielded a clear signal enhancement in liver, 
spleen and to a much larger extent in the bladder, where signal enhancement in excess of +250% 
was obtained (Figure 7). While the contrast enhancement decreased after 2 hours in the bladder 
(Figure 7C), it was slightly increased over time in liver reaching a value of +27% after 320 
min (Figure 7AB). In spleen the signal reached a maximum after two hours (+16%) and then 
decreased to close to its initial value (+3%). Histological specimens of hepatic and splenic 
tissues confirmed the presence of nanotubes with a spotty homogenous distribution in liver and 






Figure 7 : A) MRI contrast enhancement in liver, spleen, kidneys and bladder following 
intravenous injection of Gd-CNT 5 (5 mg/mL, 100 µL) in comparison to the signal prior 
injection. Standard deviations are deduced from three independent measurements. B-C) 
Example of MR slices showing liver (L), spleen (S) and kidney (K) (B) or bladder (B) (C) at 
different-time points before and after injection of Gd-CNTs. A fast spin echo RARE T1-
weighted sequence was used with TE/TR = 445/12 ms. 
 
 
Figure 8 : Histological (left) and transmission electron microscopy (TEM) (right) micrographs 
of liver (A) and spleen (B) 6 hours after injection of Gd-CNTs 5. A) Note the homogenous 




stained with Nuclear Fast Red, Mag x20). TEM shows that Gd-CNTs are mainly localized in 
endosomes within Kupffer cells (N-h: nuclei of hepatocytes, N-K: nucleus of the Kupffer cell, 
asterisks: glycogen, white arrowhead: endosome containing nanotubes and its magnified view 
in the inset. White arrows point to nanotubes). B) Black arrows point to Gd-CNT aggregates 
(brown spots on histology (left)) within the spleen (Nuclear Fast Red and Pearls staining, which 
reveals endogenous iron storage ferritin (blue spots), Mag x10). Aggregates are mainly 
localized in the periphery or, in case of smaller aggregates, in the center of the white pulp. TEM 
micrographs show Gd-CNTs localized in endosomes of phagocytic cells (N: nuclei, red square: 
endosome containing nanotubes and its magnified view on the right). 
 
 
Figure 9. A) TEM of liver 6 hours after injection of Gd-CNTs. B) EELS analysis on carbon K-
edge can differentiate between Gd-CNTs and the carbon rich cellular background. The strength 
of the first sharp peak (285 eV) due to the 1s to 2π* can be related to the predominance of sp2 
hybridizations. Therefore, the strong initial peak unambiguously reveals the presence of carbon 
nanotubes in liver. This characteristic signal is easily differentiated from the carbon rich cellular 
background which shows an amorphous carbon-like K-edge. C) EDX spectrum confirms the 
presence of Gd on CNTs internalized by liver Kupffer cells.  
 
 
Unambiguous identification of carbon nanotubes in the intracellular compartments of Kupffer 
cells in liver was provided by electron energy loss spectroscopy spectrum (EELS). This 




from the endogenous cellular background or from carbon membranes present on TEM grids 
(Figure 9).[41] Moreover, EDX spectroscopy also confirmed the presence of gadolinium co-
localizing with carbon nanotubes within membrane-bound intracellular compartments that are 
presumably lysosomes, in both liver and spleen (Figure 9). Thus, the increased MR signal in 
these organs is unambiguously related to the rapid uptake of CNTs by the reticuloendothelial 
system, as confirmed by histology and TEM. The massive and transient signal enhancement in 
bladder also suggests that a significant fraction of Gd-CNTs is eliminated by renal clearance. 
Both histology and TEM confirmed MRI results showing that Gd-CNTs do not accumulate in 
the kidneys (as only one isolated aggregate was observed in histological sections), which is 
consistent with effective elimination in the urine (Supporting Figure S7). Overall, our findings 
are consistent with the recent SPECT/CT imaging study on functionalized CNTs radiolabeled 
with 111Indium-DTPA. Different distribution profiles have been reported with a balance of renal 
clearance versus RES accumulation depending on the degree of chemical functionalization of 
the nanotubes.[16a] Individual functionalized CNTs with outer diameter lower than the 
glomerular filtration cut-off have been shown to escape the glomerular kidney filter to be 
excreted in urines in several studies.[42] In contrast, most of the largest CNTs or CNTs forming 
bundles in vivo are uptaken in liver, spleen and lung.[5] Therefore, full dispersion (or 
individualization) of CNTs which is favored by chemical functionalization appears to be a 
pivotal factor determining their excretion profile. In the present study, a single bolus injection 
of a relatively high dose of Gd-CNTs (250 µg versus 50 µg and 10 µg in two recent 
studies[16a,26]) was used with no acute or sub-acute effect on the animal behavior apparent (until 
day 8 post-injection) and with no signs of tissue damage, inflammatory response and cellular 
toxicity that could be noticed on histological and TEM micrographs in liver, spleen, kidney and 
lung. This clearly indicates that the dispersion of the functionalized nanotubes in physiological 
saline medium at the concentration of 5 mg/mL was appropriate for intravenous administration. 




systemic administration,[5] the lung histological specimens show very few nanotubes despite 
the high dose injected (Supporting Figure S7). The lack of lung accumulation is a further 
indication of the good dispersibility of Gd-CNTs which persists in blood circulation. The 
ultrastructural examination of Gd-CNTs in liver and spleen also revealed that well 
individualized CNTs could be sequestered into intracellular compartment while keeping their 
native hollow and elongated structure (Figure 8). A similar intracellular distribution of CNTs 
was still observed 8 days after injection. This suggests that individual as well as CNT clusters 
were internalized in the first hours post-injection. 
3. Conclusion 
In conclusion, we covalently functionalized oxidized MWCNTs with DTPA for chelation of 
Gd3+ and the Gd-CNTs were administrated intravenously to mice. The CNT uptake in liver and 
spleen could be successfully assessed using in vivo MRI owing to the preserved capacity of Gd-
CNTs to generate signal enhancement after cellular internalization. In addition, the rapid 
clearance into the urines of extracellular functionalized CNTs confirmed previous studies using 
other different imaging modalities.[43] Overall, this study represents the first success in 
monitoring the CNT distribution with functionalized tubes used to generate a T1 positive MR 
contrast after intravenous injection. This work shows that combining the properties of Gd3+ and 
CNTs allows performing MRI in vivo. MRI has a high resolution compared to other imaging 
techniques and can thus be used as an alternative imaging method to track CNTs. Despite the 
fact that the amount of gadolinium chelates injected with nanotubes is far lower the gadolinium 
dose in clinical practice (5.75 µmol/kg versus 100 µmol/kg body weight), the high longitudinal 
relaxivity of Gd-CNT conjugates enabled their detection with T1-weighting in mice using a 4.7 
T scanner. In contrast to other strategy using nanoparticles to enhance MR contrast of carbon 
materials, the present approach exploits paramagnetic molecular chelates that are widely used 
in the clinics and minimally interfere with the structure, dispersability, functionalization, 




could open new routes to highly dispersible nanomaterials functionalizable with significant 
payloads for drug delivery, tumor targeting and photothermal therapy or vaccination. The 
second aspect is the retention of T1-weighting properties for MRI following cellular uptake, 
which may provide possibilities for study the biodistribution of functionalized CNTs and for 
image guided delivery. 
 
4. Experimental Section 
Preparation of MWCNTs 
MWCNTs (20-30 nm diameter, 0.5-2 µm length, 95% purity; batch 1240XH) were purchased 
from Nanostructured and Amorphous Materials. When stated, suspensions of CNTs were 
sonicated in a water bath (Transsonics Digitals Elma, 20 W, 40 kHz). All reagents and solvents 
were purchased from different commercial suppliers and used as received. In particular, xylenol 
orange tetrasodium salt was purchased from Alfa Aesar. Thermogravimetric analyses were 
performed by using a TGA Q500 TA instrument with a ramp of 10 °C·min-1 under N2 using a 
flow rate of 60 mL·min-1. 1H and 13C NMR spectra were recorded on Bruker DPX 300 
instrument. The peak values were obtained as ppm () and referenced to the solvent. The 
resonance multiplicity is indicated as s (singlet), br s (broad singlet), and m (multiplet). LC/MS 
analyses were performed on ThermoFisher Finnigan 6 LCQ Advantage Max. TLC was 
performed on aluminum sheets coated with silica gel 60 F254 (Merck, Darmstadt). 
Chromatographic purification was done with Merck silica gel (Kiesegel 60, 40-60 µm, 230-400 
mesh ASTM). Dialysis was performed using Spectra/Por® dialysis membrane, MWCO: 12-
14,000 Da. 
Synthesis of DTPA ligand 2 
[(2-Bromo-ethyl)-tert-butoxycarbonylmethyl-amino]-acetic acid tert-butyl ester 9 
To a solution of tert-butylbromoacetate (9.96 mL, 0.067 mol) and N,N-diisopropylethylamine 




bromoethylamine hydrobromide (4.61 g, 0.022 mol) in DMF (20 mL). The reaction mixture 
was stirred at room temperature for 1 day. Water and ethyl acetate were added and the two 
phases were separated. The organic phase was washed with water (3 times) and brine, dried 
over Na2SO4, filtered and evaporated under vacuum. The crude was purified by 
chromatography on silica gel using ethyl acetate/cyclohexane from 3:97 to 7/93 as eluant. 3.73 
g of compound 9 was obtained as colorless oil (yield: 47%). The 1H NMR spectrum was in 
agreement with literature.[44] 
6-Benzyloxycarbonylamino-2-{bis-[2-(bis-tert-butoxycarbonylmethyl-amino)-ethyl]-
amino}-hexanoic acid tert-butyl ester 10 
To a solution of the brominated compound 9 (6.54 g, 0.019 mol) and DIEA (3.87 mL, 0.022 
mol) in acetonitrile (32 mL) was added a solution of H-Lys(Z)-OtBu·HCl (2.78 g, 0.0074 mol) 
in a phosphate buffer (Na2HPO4: 1.1 g/KH2PO4: 0.137 g, pH 8) (36 mL). The reaction mixture 
was vigorously stirred at 40 °C for 3 days. Water and ethyl acetate were added and the two 
phases were separated. The organic phase was washed with water (twice) and brine, dried over 
Na2SO4, filtered and evaporated under vacuum. The crude was purified by chromatography on 
silica gel using ethyl acetate/cyclohexane from from 20/80 to 60/40 as eluant. 3.53 g of 
compound 10 was obtained as yellow oil (yield: 54%). The 1H NMR spectra were in agreement 
with literature.[28] LC-MS (ESI): m/z 879.6 [M + H]+. 
6-Amino-2-{bis-[2-(bis-tert-butoxycarbonylmethyl-amino)-ethyl]-amino}-hexanoic acid 
tert-butyl ester 2 
To a solution of compound 10 (1.77 g, 2.0 mmol) in methanol (20 mL) was added a catalytic 
amount of Pd/C. The mixture was stirred at room temperature under a hydrogen atmosphere for 
17 h. The suspension was filtered over celite and the filtrate was evaporated under vacuum to 
give compound 2 as colorless oil (1.33 g, 85%) with a satisfactory purity. The 1H and 13C NMR 
spectrum was in agreement with literature (Anelli, Bioconjugate Chem. 1999, 137). LC-MS 




Synthesis of Gd-DTPA ligand 8 
6-Acetylamino-2-{[2-(bis-tert-butoxycarbonylmethyl-amino)-ethyl]-[2-(tert-
butoxycarbonylmethyl-isopropoxycarbonylmethyl-amino)-ethyl]-amino}-hexanoic acid 
tert-butyl ester 6 
To a solution of compound 2 (166 mg, 0.23 mmol) in methanol (2.3 mL) was added acetic 
anhydride (24 µL, 0.25 mmol), and the mixture was stirred at room temperature. The reaction 
was monitored by TLC. After 7 h, the reaction mixture was evaporated under vacuum to give 
171 mg of compound 6 as a yellow oil (yield: 98%) with a satisfactory purity. 1H NMR (300 
MHz, CDCl3):  6.05 (br s, 1 H), 3.41 (s, 8 H), 3.31-3.16 (m, 3 H), 2.84-2.58 (m, 8 H), 1.91 (s, 
3 H), 1.64-1.22 (m, 51 H). 13C NMR (75 MHz, CDCl3): 172.9, 170.8, 170.2, 81.0, 80.8, 63.9, 
56.0, 53.7, 50.2, 39.4, 29.5, 29.0, 28.4, 28.3, 23.6, 23.4. LC/MS (ESI): m/z 787.3 [M + H]+. 
6-Acetylamino-2-{bis-[2-(bis-carboxymethyl-amino)-ethyl]-amino}-hexanoic acid 7 
A solution of compound 6 (39 mg, 0.050 mmol) in TFA (0.9 mL) and water (0.1 mL) was 
stirred at room temperature for 1 day. The reaction was monitored by LC/MS. The reaction 
mixture was precipitated in diethyl ether and filtered. The solid was dissolved in water and the 
solution was lyophilized to give 17 mg of compound 7 as a beige solid (yield: 68%) with a 
satisfactory purity. 1H NMR (300 MHz, DMSO):  3.35 (s, 8 H), 3.41-3.28 (m, 3 H), 3.10-2.98 
(m, 8 H), 1.90-1.81 (m, 2 H), 1.79 (s, 3 H), 1.52-1.31 (m, 4 H). 13C NMR (75 MHz, DMSO): 
172.6, 171.4, 169.1, 63.9, 54.4, 50.6, 50.3, 38.3, 29.1, 27.1, 23.6, 22.6. LC/MS (ESI): m/z 507.3 
[M + H]+. 
Gd-DTPA ligand 8 
A solution of DTPA ligand 7 (9.4 mg) in a solution of gadolinium(III) perchlorate aqueous 
solution (Strem Chemicals) (14.9 µmol) in water (9.4 mL) was stirred at room temperature for 
3 days. An aliquot of the solution was titrated with xylenol orange to check that there was no 
more free Gd. The solution was lyophilized to obtain Gd-DTPA ligand 8. 





A suspension of pristine MWCNTs (1 g) in a mixture of sulfuric acid 98% (108 mL) and nitric 
acid 65% (36 mL) was sonicated in a water bath for 24 h. The temperature was kept below 
35 °C. Deionized water was then carefully added and the CNTs were filtered (OmniporeTM 
membrane filtration, 0.45 µm), re-suspended in water, filtered again until pH became neutral 
and dried under vacuum. 
Functionalized CNTs 3 
A suspension of ox-CNTs 1 (21 mg) in oxalyl chloride (8.5 mL) was sonicated in a water bath 
for 30 min and then heated at reflux for 24 h. After evaporation under vacuum, the acyl chloride-
CNTs were dispersed in a solution of DTPA ligand 2 (237 mg) in dry THF (10 mL). The mixture 
was sonicated for 2 min and then heated at reflux for 60 h. The suspension was filtered over a 
PTFE membrane (0.1 µm, OmniporeTM, Millipore). The solid recovered on the filter was 
dispersed in DMF (100 mL), sonicated for 3 min in a water bath, and filtered over a PTFE 
membrane (0.1 µm). This sequence was repeated with DMF, methanol (twice), and 
dichloromethane. The resulting solid was dried under vacuum. 
DTPA/CNTs 4 
A suspension of the functionalized CNTs 3 (21 mg) in TFA (1.8 mL) and water (200 µL) was 
sonicated in a water bath for 3 min and stirred at room temperature for 2 h. A solution of TFA 
(1.8 mL) and water (200 µL) was added and the mixture was further stirred for 18 h. After 
evaporation under vacuum, diethyl ether was added and the mixture was evaporated under 
vacuum. The residue was dispersed in water and dialyzed against water for 2 days. The 
suspension was lyophilized to obtain DTPA/CNTs 4.  
Gd-CNTs 5 
A suspension of DTPA/CNTs 4 (8.3 mg) in a solution of gadolinium(III) perchlorate 50% 
aqueous solution (4.04 µmol) in water (8.3 mL) was sonicated for 30 min and stirred at rt for 




orange to assess the amount of free Gd. The reaction mixture was then dialyzed against water 
for 2 days. The suspension was lyophilized to obtain Gd-CNTs 5.  
 
Aberration-corrected high resolution transmission electron microscopy (HR-TEM), energy-
dispersive X-ray spectroscopy (EDX) and high angle annular dark field scanning transmission 
electron microscopy (HAADF)-STEM. HR-TEM investigations were performed with the newly 
developed JEOL ARM 200 F microscope operating at 80 kV. This microscope is equipped 
together with a CEOS aberration corrector, a cold field emission gun, a Gatan GIF quantum ER 
and a JEOL EDX Diode.[45]   
HAADF-STEM images and EDX spectra were acquired on a FEI Tecnai G2 F20 HRTEM 
operated at 200 kV and equipped with an EDAX super ultra-thin window (SUTW) X-ray 
detector. Samples were deposited on lacey carbon Cu TEM grids (Agar). 
Inductively coupled plasma atomic emission spectrometry (ICP-AES) analysis. Determination 
of gadolinium, iron and nickel content in CNTs was performed by ICP-AES analysis (Agilent 
7500ce). The samples were digested in concentrated HNO3 (3:1, v/v) solution and diluted with 
ultrapure water for the analysis.   
Magnetization measurements. Magnetic measurements were carried out on a Quantum Design 
MPMS-5S SQUID Magnetometer. Field-dependent magnetization curves were measured at 5K 
as function of the external field in the range 0 – 5 Tesla. Field-cooled (FC) and Zero-field-
cooled (ZFC) temperature-dependant magnetization was measured using a magnetic field of 
100 Oe or 1000 Oe and the sample was cooled with the same magnetic field. 
NMRD and relaxivity measurements. The frequency dependence of the 1H relaxation for the 
aqueous nanotube suspensions was recorded over the frequency range 0.01–20 MHz using a 
Spinmaster FFC-2000 Fast Field Cycling NMR Relaxometer (Stelar SRL, Mede, Italy). T1 
measurements were performed as a function of external field, B0, with standard pulse sequences 




using a thermostated airflow system. All of the 1H magnetisation recovery curves were singly 
exponential within experimental error and the random errors in fitting T1 were always less than 
1%. T2 was measured using the CPMG pulse sequence at 20, 40 and 60 MHz using the Stelar 
spectrometer and a reconditioned Bruker WP80 electromagnet. T2 was measured using the 
CPMG pulse sequence at 20, 40 and 60 MHz. Images of CNT liquid suspensions, agarose gel 
(0.3%) and cell samples (7×106 cells in 70 µL agarose) were obtained on a Bruker Bio-Spec 
47/40 USR scanner operating at 4.7T (200MHz) using fast spin echo sequences with variable 
echo time TE and repetition time TR. T1 and T2 were deduced from monoexponential fit of MR 
signal as function of TR and TE, respectively, using the ParaVision software. 
Cell culture, cell labeling, cell metabolic activity and cell preparation for TEM 
The murine macrophage RAW 264.7 cells were maintained as monolayer cultures in RPMI 
(Roswell Park Memorial Institute) medium supplemented with 10% fetal bovine serum, 1% 
penicillin-streptomycin at 37°C and 5% of CO2. For cell labeling, cells were incubated with 
complete RPMI medium supplemented with CNTs at concentration of 10, 20, 50, 100 µg/mL 
for 20 hours at 37°C.  
Cell metabolic activity was assessed by the Alamar blue test in 48-well plates seeded with cells 
the day before labeling. The labeled macrophages were washed twice in PBS and were 
incubated with 10% Alamar Blue in culture medium for 2 hours. The fluorescence in cell 
medium due to the reduction of resazurin (oxidized form) to resorufin by cell activity was 
quantified on a FLUOstar OPTIMA microplate reader (excitation 550 nm, emission 590 nm) 
and normalized to the fluorescence signal of the control non-labeled cells. The conditions were 
run in quadruplicate.  
For TEM observation, cells were trypsinized, centrifuged at 1200 rpm for 5 min, washed in 0.1 
M cacodylate buffer and fixed with 2.5% glutaraldehyde in cacodylate buffer at 4 °C for 30 
min. Cells were then post-fixed with osmium tetraoxide 1% and passed through uranyl acetate. 




medium (EPON 812; Shell Chemical, San Francisco, California). Thin sections (70 nm) were 
collected onto 200 mesh cooper grids, and counterstained with lead citrate before examination 
with Zeiss EM902 electron microscope operated at 80 kV (MIMA2- UR1196 Génomique et 
Physiologie de la Lactation, INRA, Plateau de Microscopie Electronique 78352, Jouy en Josas, 
France). 
Imaging flow cytometry. For imaging flow cytometry analysis, labeled macrophages were 
trypsinized, fixed with 4% formaldehyde in PBS and centrifuged to obtain a pellet of about 106 
cells in 50 µL. Cell images were acquired using the ImageStreamX multispectral imaging flow 
cytometer (Amnis Corporation), collecting 10,000 events per sample at 40x magnification. 
Dark field images were acquired using a 785 nm laser. Cell images were analyzed using 
IDEAS® image-analysis software (Amnis). Gating on bivariate plot of aspect ratio versus cell 
area was first used to isolate a population of single cells. Cells within the focal plane were 
further selected using a two-dimensional plot of image contrast versus root mean squared 
(RMS) gradient. Mean pixel feature on bright field images versus intensity feature on dark field 
images was used as a biparametric dot plot to discriminate cells with respect to their CNT 
uptake.  
Animal experiments and MRI protocol. Animal experiments were conducted in line with French 
Agriculture Ministry guidelines. During the MRI protocol the animals were anesthetized with 
2% isofluorane (Aerrane, Baxter, Maurepas, France) supplied in an air mixture, while their 
body temperature was kept constant by circulating thermostated warm water. Twelve eight-
weeks-old female C57/Bl6 mice (mean weight 20.5±1 g) (Janvier, France) were used in this 
study.  
The mice were imaged by the whole body MRI 20 min before injection and 10, 75, 120, 320 
min after injection of Gd-CNTs in the retro-orbital sinus at a dose of 1 or 5 mg/mL suspended 
in a 100 µL physiological saline medium. Three animals were analyzed at each time point. MRI 




scanner interfaced to ParaVision software (both provided from Bruker Biospin GmbH, 
Rheinstetten, Germany). The whole body imaging protocol was performed with a volume 
transmission/reception RF coil for mice (Bruker), using a fast spin echo (Turbo RARE) 
sequence with a TE of 12 ms and a TR of 445 ms (T1-weighted sequence), flip angle of 180°, 30 
averages, in-plane resolution of 150 μm, slice thickness of 500 nm, for a total of seven slices. 
At the end of the experimental protocol, mice were sacrificed with a lethal injection of sodium 
pentobarbital. Livers, spleens, lungs and kidneys were excised and prepared for histological 
and TEM characterizations. 
Image processing and analysis were made with the open source software OsiriX (3.9.2. 











, with the contrast-to-noise ratio (CNR) measured in 










SNR  , where ref denotes the water tube reference and SD 
is the standard deviation of the noise in the image. A water tube, used as a reference, was 
positioned near the mice to enable CNR measurement and 1H NMR signal normalization. ROIs 
encompassing the liver parenchyma, the whole spleen, the kidneys and the bladder were 
manually selected for signal measurement. 
Histology.   After excision, pieces of liver, spleen, lung and kidney were fixed with pH 7.4 
phosphate-buffered 10% formalin and processed by embedding in paraffin. Sections, ~6 m 
thick, were evaluated after hematoxylin and eosin or Nuclear Fast Red and Pearl’s staining (all 
from Sigma-Aldrich, Steinheim, Germany). 
Transmission electron microscopy in organs. Organs were cut into 1 mm3 pieces after excision 
and fixed with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, postfixed with 1% 




embedded in Epon. Thin sections (70 nm) of selected zones were observed with Zeiss EM902 
electron microscope operated at 80 kV as described above for cells. 
Ultra-thin sections (30 nm) of organs were specially prepared for high resolution imaging, EDX 
analysis and Electron Energy Loss Spectroscopy (EELS) analysis on the carbon K-edge at 284 
eV, performed on the aberration-corrected JEOL ARM 200F operating at 80 kV.  
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Figure S1. TEM image of ox-CNTs 1 (a) and Gd-CNTs 5 (b) (Low resolution TEM images 
were recorded at the RIO Microscopy Facility Platform of Esplanade Campus (Strasbourg, 






























































































































































Figure S3: Synthesis of Gd-DTPA ligand 8. 
 
 
Figure S4: Metabolic activity of RAW 267.4 macrophages after 20 h incubation with Gd-







Figure S5: Histological specimens of liver after Hematoxylin- Eosin staining. Optical 
Magnification x2.5, x10, x20 and x63. White arrow points to Gd-CNT aggregates. 
 
Figure S6: Histological specimens of spleen after Pearls and Nuclear Red staining, optical 







Figure S7. Histological micrographs of lung (nuclear red staining) and kidney (hematoxylin-
eosin staining) at 6 hours following Gd-CNTs injection. Gd-CNTs are very rare both in lung 
and kidneys. White arrow points to a CNT aggregate in the kidney. (Optical magnification is 
indicated on the picture). 
 
 
 
 
